“Real-World Data on the Incidence of Immune-Related Adverse Events Associated With Anti-PD-1 PD-L1 Treatment in Russia”. 2022. Voprosy Onkologii 68 (2): 188-99. https://doi.org/10.37469/0507-3758-2022-68-2-188-199.